415 related articles for article (PubMed ID: 26017734)
1. PET/MRI and PET/CT in advanced gynaecological tumours: initial experience and comparison.
Queiroz MA; Kubik-Huch RA; Hauser N; Freiwald-Chilla B; von Schulthess G; Froehlich JM; Veit-Haibach P
Eur Radiol; 2015 Aug; 25(8):2222-30. PubMed ID: 26017734
[TBL] [Abstract][Full Text] [Related]
2. Integrated versus separate reading of F-18 FDG-PET/CT and MRI for abdominal malignancies - effect on staging outcomes and diagnostic confidence.
Min LA; Vogel WV; Lahaye MJ; Maas M; Donswijk ML; Vegt E; Kusters M; Zijlmans HJ; Jóźwiak K; Roberti S; Beets-Tan RGH; Lambregts DMJ
Eur Radiol; 2019 Dec; 29(12):6900-6910. PubMed ID: 31119418
[TBL] [Abstract][Full Text] [Related]
3. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience.
Squillaci E; Manenti G; Mancino S; Cicciò C; Calabria F; Danieli R; Schillaci O; Simonetti G
Abdom Imaging; 2008; 33(6):676-88. PubMed ID: 18373114
[TBL] [Abstract][Full Text] [Related]
4. Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.
Michielsen K; Vergote I; Op de Beeck K; Amant F; Leunen K; Moerman P; Deroose C; Souverijns G; Dymarkowski S; De Keyzer F; Vandecaveye V
Eur Radiol; 2014 Apr; 24(4):889-901. PubMed ID: 24322510
[TBL] [Abstract][Full Text] [Related]
5. Staging of neuroendocrine tumours: comparison of [⁶⁸Ga]DOTATOC multiphase PET/CT and whole-body MRI.
Schraml C; Schwenzer NF; Sperling O; Aschoff P; Lichy MP; Müller M; Brendle C; Werner MK; Claussen CD; Pfannenberg C
Cancer Imaging; 2013 Mar; 13(1):63-72. PubMed ID: 23466785
[TBL] [Abstract][Full Text] [Related]
6. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
Kim HJ; Cho A; Yun M; Kim YT; Kang WJ
Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncology.
Heusch P; Nensa F; Schaarschmidt B; Sivanesapillai R; Beiderwellen K; Gomez B; Köhler J; Reis H; Ruhlmann V; Buchbender C
Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):42-8. PubMed ID: 25112399
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer staging in a single session: whole-body PET/CT mammography.
Heusner TA; Kuemmel S; Umutlu L; Koeninger A; Freudenberg LS; Hauth EA; Kimmig KR; Forsting M; Bockisch A; Antoch G
J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831
[TBL] [Abstract][Full Text] [Related]
9. A two-way comparison of whole-body 18FDG PET-CT and whole-body contrast-enhanced MRI for distant metastasis staging in patients with malignant tumors: a meta-analysis of 13 prospective studies.
Li J; Zhou H; Zhang X; Song F; Pang X; Wei Z
Ann Palliat Med; 2020 Mar; 9(2):247-255. PubMed ID: 32233618
[TBL] [Abstract][Full Text] [Related]
10. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system.
Schmidt GP; Baur-Melnyk A; Herzog P; Schmid R; Tiling R; Schmidt M; Reiser MF; Schoenberg SO
Invest Radiol; 2005 Dec; 40(12):743-53. PubMed ID: 16304476
[TBL] [Abstract][Full Text] [Related]
11. Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients.
Riegger C; Herrmann J; Nagarajah J; Hecktor J; Kuemmel S; Otterbach F; Hahn S; Bockisch A; Lauenstein T; Antoch G; Heusner TA
Eur J Nucl Med Mol Imaging; 2012 May; 39(5):852-63. PubMed ID: 22392069
[TBL] [Abstract][Full Text] [Related]
12. Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer.
Schmidt GP; Baur-Melnyk A; Haug A; Utzschneider S; Becker CR; Tiling R; Reiser MF; Hermann KA
Eur Radiol; 2009 Jun; 19(6):1366-78. PubMed ID: 19190917
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and diagnostic performance of hybrid PET/MRI compared with PET/CT for gynecological malignancies: a prospective pilot study.
Schwartz M; Gavane SC; Bou-Ayache J; Kolev V; Zakashansky K; Prasad-Hayes M; Taouli B; Chuang L; Kostakoglu L
Abdom Radiol (NY); 2018 Dec; 43(12):3462-3467. PubMed ID: 29948057
[TBL] [Abstract][Full Text] [Related]
14. Combination of FDG PET/CT and contrast-enhanced MSCT in detecting lymph node metastasis of esophageal cancer.
Tan R; Yao SZ; Huang ZQ; Li J; Li X; Tan HH; Liu QW
Asian Pac J Cancer Prev; 2014; 15(18):7719-24. PubMed ID: 25292052
[TBL] [Abstract][Full Text] [Related]
15. Computed tomography, magnetic resonance imaging and FDG positron emission tomography in the management of vulvar malignancies.
Lin G; Chen CY; Liu FY; Yang LY; Huang HJ; Huang YT; Jung SM; Chou HH; Lai CH; Ng KK
Eur Radiol; 2015 May; 25(5):1267-78. PubMed ID: 25477274
[TBL] [Abstract][Full Text] [Related]
16. (18) F-FDG PET/CT for initial staging in breast cancer patients - Is there a relevant impact on treatment planning compared to conventional staging modalities?
Krammer J; Schnitzer A; Kaiser CG; Buesing KA; Sperk E; Brade J; Wasgindt S; Suetterlin M; Schoenberg SO; Sutton EJ; Wasser K
Eur Radiol; 2015 Aug; 25(8):2460-9. PubMed ID: 25680729
[TBL] [Abstract][Full Text] [Related]
17. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
Fuster D; Duch J; Paredes P; Velasco M; Muñoz M; Santamaría G; Fontanillas M; Pons F
J Clin Oncol; 2008 Oct; 26(29):4746-51. PubMed ID: 18695254
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
[TBL] [Abstract][Full Text] [Related]
19. Assessment of whole-body MRI including diffusion-weighted sequences in the initial staging of breast cancer patients at high risk of metastases in comparison with PET-CT: a prospective cohort study.
Hottat NA; Badr DA; Ben Ghanem M; Besse-Hammer T; Lecomte SM; Vansteelandt C; Lecomte SL; Khaled C; De Grove V; Salem Wehbe G; Cannie MM; Jani JC
Eur Radiol; 2024 Jan; 34(1):165-178. PubMed ID: 37555959
[TBL] [Abstract][Full Text] [Related]
20. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]